Shares of Usana Health Sciences (USNA) surged 5.13% on Tuesday, despite the company reporting mixed results for the third quarter of 2024.

Usana, a leading manufacturer of nutritional products and supplements, posted adjusted earnings per share of $0.56 for the quarter ended September 30, 2024. This figure exceeded Wall Street's expectations of $0.49 per share and marked a slight improvement over the same period last year when the company reported EPS of $0.59.

However, the company's revenue fell short of analysts' projections, declining 6.2% year-over-year to $200.22 million. Analysts had anticipated revenue of $205.77 million. Despite the top-line miss, Usana's net income for the quarter stood at a respectable $10.61 million.